Induction of cytokine synthesis by flagella from gramnegative bacteria may be dependent on the activation or differentiation state of human monocytes

Infection and Immunity

Volumn 67, Issue 10, 1999, Pages 5176-5185

  Ciacci Woolwine, Federica ^a   McDermott, Patrick F ^a   Mizel, Steven B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FLAGELLIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; ESCHERICHIA COLI; FLAGELLATE; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SALMONELLA; YERSINIA ENTEROCOLITICA;

EID: 0032833747     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.10.5176-5185.1999     Document Type: Article

References (44)

1. Agace, W. W., S. R. Hedges, M. Ceska, and C. Svanborg. 1993. Interleukin-8 and the neutrophil response to mucosal gram-negative infections. J. Clin. Investig. 92:780-785.
2. Arnold, J. W., D. W. Niesel, C. R. Annable, C. B. Hess, M. Asuncion, Y. Ja Cho, J. W. Peterson, and G. R. Klimpel. 1993. Tumor necrosis factor-α mediates the early pathology in Salmonella infection of the gastrointestinal tract. Microb. Pathog. 14:217-227.
3. Asiedu, C., J. Biggs, and A. S. Kraft. 1997. Complex regulation of CDK2 during phorbol ester-induced hematopoietic differentiation. Blood 90:3430-3437.
4. Bagasra, O., S. D. Wright, T. Seshamma, J. W. Oakes, and R. J. Pomerantz. 1992. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide. Proc. Natl. Acad. Sci. USA 89:6285-6289.
5. Beutler, B., and G. E. Grau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21:5423-5435.
6. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 229:869-871.
7. Biggs, J. R., N. G. Ahn, and A. S. Kraft. 1998. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein. Cell Growth Differ. 9:667-676.
8. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
9. Ciacci-Woolwine, F., I. C. Blomfield, and S. H. Richardson. 1998. Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line. Infect. Immun. 66:1127-1134.
10. Ciacci-Woolwine, F., L. S. Kucera, S. H. Richardson, N. P. Iyer, and S. B. Mizel. 1997. Salmonellae activate tumor necrosis factor alpha production in a human promonocytic cell line via a released polypeptide. Infect. Immun. 65:4624-4633.
11. DiMango, E., H. J. Zar, R. Bryan, and A. Prince. 1995. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J. Clin. Investig. 96:2204-2210.
12. Donnenberg, M. S., J. Yu, and J. B. Kaper. 1993. A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J. Bacteriol. 175:4670-4680.
13. Everest, P., M. Roberts, and G. Dougan. 1998. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor. Infect. Immun. 66:3355-3364.
14. Felber, B. K., and G. N. Pavlakis. 1988. A quantitative bioassay for HIV-1 based on transactivation. Science 239:184-186.
15. Galdiero, F., G. Cipollaro de L'Ero, N. Benedetto, M. Galdiero, and M. A. Tufano. 1993. Release of cytokines induced by Salmonella typhimurium porins. Infect. Immun. 61:155-161.
16. Glauser, M. P. 1996. The inflammatory cytokines: new developments in the pathophysiology and treatment of septic shock. Drugs 52(Suppl. 2):9-17.
17. Goldfeld, A. E., C. Doyle, and T. Maniatis. 1990. Human tumor necrosis factor a gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 87:9769-9773.
18. Haas, J. G., P. A. Baeuerle, G. Riethmüller, and H. W. L. Ziegler-Heitbrock. 1990. Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc. Natl. Acad. Sci. USA 87:9563-9567.
19. Holloway, B. W. 1955. Genetic recombination in Pseudomonas aeruginosa. J. Gen. Microbiol. 13:572-581.
20. Hosieth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent S. typhimurium are nonvirulent and are effective as live vaccines. Nature (London) 291:238-239.
21. Introna, M., R. C. Bast, Jr., P. A. Johnston, D. O. Adams, and T. A. Hamilton. 1987. Homologous and heterologous desensitization of protooncogene cfos expression in murine peritoneal macrophages. J. Cell. Physiol. 131:36-42.
22. Kanto, S., H. Okino, S.-I. Aizawa, and S. Yamaguchi. 1991. Amino acids responsible for flagellar shape are distributed in terminal regions of flagellin. J. Mol. Biol. 219:471-480.
23. Kastenbauer, S., and H. W. Löms Ziegler-Heitbrock. 1999. NF-KB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect. Immun. 67:1553-1559.
24. + mutant. Gene 136:271-275.
25. König, B., M. Ceska, and W. König. 1995. Effect of Pseudomonas aeruginosa on interleukin-8 release from human phagocytes. Int. Arch. Allergy Appl. Immunol. 106:357-365.
26. Kriegler, M., C. Perez, K. DeFay, I. Albert, and S. D. Lu. 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45-53.
27. Maloy, S. R., V. J. Stewart, and R. K. Taylor. 1996 Genetic analysis of pathogenic bacteria: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
28. Montie, T. C., R. C. Craven, and I. A. Holder. 1982. Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization. Infect. Immun. 35:281-288.
29. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818.
30. Morrison, D. C., and J. L. Ryan. 1979. Bacterial endotoxins and host immune responses. Adv. Immunol. 28:293-450.
31. Munoz, C., J. Carlet, C. Fitting, B. Misset, J.-P. Blériot, and J.-M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Investig. 88:1747-1754.
32. Nakano, Y., K. Onozuka, Y. Terada, H. Shinomiya, and M. Nakano. 1990. Protective effect of recombinant tumor necrosis factor-α in murine Salmonellosis. J. Immunol. 144:1935-1941.
33. Newton, S. M. C., R. D. Wasley, A. Wilson, L. T. Rosenberg, J. F. Miller, and B. A. D. Stocker. 1991. Segment IV of a Salmonella flagellin gene specifies flagellar antigen epitopes. Mol. Microbiol. 5:419-425.
34. Raggs, S. J., S. Kaga, K. A. Berg, and A. Ochi. 1998. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. J. Immunol. 161:1390-1398.
35. Robache-Gallea, S., J. M. Bruneau, H. Robbe, V. Morand, C. Capdevila, N. Bhatnagar, S. Chouaib, and S. Roman-Roman. 1997. Partial purification and characterization of a tumor necrosis factor-alpha converting activity. Eur. J. Immunol. 27:1275-1282.
36. Stone, B. J., C. M. Garcia, J. L. Badger, T. Hassett, R. I. F. Smith, and V. L. Miller. 1992. Identification of novel loci affecting entry of Salmonella enteritidis into eukaryotic cells. J. Bacteriol. 174:3945-3952.
37. Tite, J. P., G. Dougan, and S. N. Chatfield. 1991. The involvement of tumor necrosis factor in immunity to Salmonella infection. J. Immunol. 147:3161-3164.
38. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
39. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662-666.
40. van Asten, A. J. A. M., K. A. Zwaagstra, M. F. Baay, J. G. Kusters, J. H. J. Huis in't Veld, and B. A. M. van der Zeijst. 1995. Identification of the domain which determines the g,m serotype of the flagellin of Salmonella enteritidis. J. Bacteriol. 177:1610-1613.
41. Volk, H. D., P. Reinke, D. Krausch, H. Zuckermann, K. Asadullah, J. M. Muller, W. D. Docke, and W. J. Kox. 1996. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 22(Suppl. 4):S474-S481.
42. Vrana, J. A., A. M. Saunders, S. P. Chellappan, and S. Grant. 1998. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937). Differentiation 63:33-42.
43. Wyant, T. L., M. K. Tanner, and M. B. Sztein. 1999. Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells. Infect. Immun. 67:1338-1346.
44. Yamaguchi, S., H. Fujita, K. Sugata, T. Taira, and T. Iino. 1984. Genetic analysis of H2, the structural gene for phase-2 flagellin in Salmonella. J. Gen. Microbiol. 130:255-265.